Evicenter
MarkdownMedical informationP&T meetings
Ficerafusp alfa (BCA101)

First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab

Last updated
135 sources

Economic information and modeling reportBudget impact modelResults

Scenario analyses

2 evidence topics · 4 sources

Budget impact model of ficerafusp alfa: scenario analyses

No evidence found.